The Protocol Paradox: Are We Treating Guidelines or Patients?
18 November, 2025 2:00 p.m. to 3:00 p.m. EST
Traditional medical management has historically relied heavily on protocols designed to standardize medical care, and reduce variation, to increase quality. However, the era of precision diagnostics, patient centered outcomes, real-world data, and novel therapeutics challenges this ‘one-size-fits-all’ approach. This webinar explores how personalized medicine is reshaping practice across MCS, transplant and pulmonary hypertension. Protocolized management might be tested and safe but has the potential to over- or under-treat. On the other hand, personalized medicine, using biomarkers, pharmacogenomics, and device data, offers precision medicine that MIGHT be just as effective, whilst minimizing side effects. The cynic might call these 'fads,' however others might identify a real difference between patients and the care that they need, necessitating personalized medicine. Ultimately, the challenge for us as clinicians is where the rubber meets the road - to balance innovation with safety and cost-effectiveness – to determine if personalization truly changes outcomes or just adds complexity…. Are you in?
Watch Session RecordingModerators
Amanda Ingemi, PharmD, MPH
Mark Greer, MB, BCh
Presentations
One-Size Fits All or All-In-One: Precision In Transplant Medicine
Presented by Krysta Walter, PharmD
PH Power Play: Turning Data into Action
Presented by Sarah Cullivan, MB, BAO, BCh
Making It Personal: Rethinking Anticoagulation in the Era of HM3
Presented by Ian Hollis, PharmD
